Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 7, Number 5, November 2008


Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction
pp. 422-441(20)
Authors: Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.


Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
pp. 442-453(12)
Authors: Shippenberg, T. S.; LeFevour, A.; Chefer, V. I.


Free Content The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy
pp. 454-467(14)
Authors: Engleman, E. A.; Rodd, Z. A.; Bell, R. L.; Murphy, J. M.


The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
pp. 468-481(14)
Authors: Scherma, Maria; Fadda, Paola; Foll, Bernard L.; Forget, Benoit; Fratta, Walter; Goldberg, Steven R.; Tanda, Gianluigi


Glutamate: The New Frontier in Pharmacotherapy for Cocaine Addiction
pp. 482-491(10)
Authors: Uys, Joachim D.; LaLumiere, Ryan T.


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more